LASP1 and breast carcinoma: Although only 30.7% of the invasive ductal carcinoma samples with cytosolic LASP-1 expression are positive for Ki67 staining, 68.7% of the breast cancer tissues with nuclear LASP-1 occurrence show positive staining for the proliferation marker Ki67 (χ2 test; P=0.04).